Literature DB >> 1736766

Ingestion of yogurt containing Lactobacillus acidophilus as prophylaxis for candidal vaginitis.

E Hilton1, H D Isenberg, P Alperstein, K France, M T Borenstein.   

Abstract

OBJECTIVE: To assess whether daily ingestion of yogurt containing Lactobacillus acidophilus prevents vulvovaginal candidal infections.
DESIGN: Crossover trial for at least 1 year during which patients were examined for candidal infections and colonizations while receiving either a yogurt-free or a yogurt-containing diet. Patients served as their own controls.
SETTING: Ambulatory infectious disease center in a teaching hospital providing tertiary care. PATIENTS: Thirty-three women with recurrent candidal vaginitis were eligible after recruitment from community practices and clinics and through advertising. Twelve patients were eliminated for protocol violations. Of the remaining 21 patients, 8 who were assigned to the yogurt arm initially refused to enter the control phase 6 months later. Thus, 13 patients completed the protocol.
INTERVENTIONS: Women ate yogurt for 6 months of the study period. MEASUREMENTS: Colonization of lactobacilli and candida in the vagina and rectum; candidal infections of the vagina. MAIN
RESULTS: Thirty-three eligible patients were studied. A threefold decrease in infections was seen when patients consumed yogurt containing Lactobacillus acidophilus. The mean (+/- SD) number of infections per 6 months was 2.54 +/- 1.66 in the control arm and 0.38 +/- 0.51 per 6 months in the yogurt arm (P = 0.001). Candidal colonization decreased from a mean of 3.23 +/- 2.17 per 6 months in the control arm to 0.84 +/- 0.90 per 6 months in the yogurt arm (P = 0.001).
CONCLUSION: Daily ingestion of 8 ounces of yogurt containing Lactobacillus acidophilus decreased both candidal colonization and infection.

Entities:  

Mesh:

Year:  1992        PMID: 1736766     DOI: 10.7326/0003-4819-116-5-353

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  48 in total

1.  What to do with the patient with recurrent vulvovaginal candidiasis.

Authors:  J S Bingham
Journal:  Sex Transm Infect       Date:  1999-08       Impact factor: 3.519

2.  Probiotics and functional foods in gastrointestinal disorders.

Authors:  M H Floch; J Hong-Curtiss
Journal:  Curr Gastroenterol Rep       Date:  2001-08

3.  Is There a Protective Role for Vaginal Flora?

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-10       Impact factor: 3.725

4.  Interpreting the evidence.

Authors:  Des Spence
Journal:  BMJ       Date:  2002-09-14

5.  Biotherapeutic effects of probiotic bacteria on candidiasis in immunodeficient mice.

Authors:  R D Wagner; C Pierson; T Warner; M Dohnalek; J Farmer; L Roberts; M Hilty; E Balish
Journal:  Infect Immun       Date:  1997-10       Impact factor: 3.441

Review 6.  Clinical and cost considerations in the pharmacotherapy of vulvovaginal candidiasis.

Authors:  I W Fong
Journal:  Pharmacoeconomics       Date:  1996-06       Impact factor: 4.981

7.  Vulvovaginal Candidosis (excluding chronic mucocutaneous candidosis). Guideline of the German Society of Gynecology and Obstetrics (AWMF Registry No. 015/072, S2k Level, December 2013).

Authors:  W Mendling; K Friese; I Mylonas; E-R Weissenbacher; J Brasch; M Schaller; P Mayser; I Effendy; G Ginter-Hanselmayer; H Hof; O Cornely; M Ruhnke
Journal:  Geburtshilfe Frauenheilkd       Date:  2015-04       Impact factor: 2.915

Review 8.  Probiotics and medical nutrition therapy.

Authors:  Amy C Brown; Ana Valiere
Journal:  Nutr Clin Care       Date:  2004 Apr-Jun

9.  Effect of lactobacillus in preventing post-antibiotic vulvovaginal candidiasis: a randomised controlled trial.

Authors:  Marie Pirotta; Jane Gunn; Patty Chondros; Sonia Grover; Paula O'Malley; Susan Hurley; Suzanne Garland
Journal:  BMJ       Date:  2004-08-27

10.  Rapidly progressive kidney failure induced by fungal mycelia obstructing indwelling ureteral stents.

Authors:  Marie Dubert; Valeria Loi; Mohamed Tligui; Alexandre Hertig
Journal:  BMJ Case Rep       Date:  2012-12-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.